Intralytix (United States)
Intralytix, Inc. is a privately owned biotech venture incorporated in the State of Maryland on July 28, 1998. Intralytix specializes in bacteriophage based products used to control bacterial pathogens in environmental, agricultural, food processing, and medical settings. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Intralytix (United States), United States, covering academic research published from 2002 to 2023. Read More.
Open Access Percentage
75%
Total
Publications
68
Total Open
Publications
51
Total
Citations
3.8K
Open Access
Percentage
75%
Total
Publications
68
Total Open
Publications
51
Total
Citations
3.8K
Breakdown
Publisher Open
21%
Both
41%
Other Platform Open
13%
Closed
25%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 31%
13
Hybrid 45%
19
No Guarantees 24%
10
Other Platform Open
Domain 84%
31
Institution 24%
9
Public 14%
5
Preprint 8%
3
Other Internet 5%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 31 |
Europe PMC | Domain | 26 |
Semantic Scholar | Public | 4 |
Vrije Universiteit Amsterdam - VU Research Portal | Institution | 3 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Inria | Institution | 2 |
Ghent University - Ghent University Academic Bibliography | Institution | 2 |
DOI | Other Internet | 2 |
bioRxiv | Preprint | 2 |
University of Leeds, The University of Sheffield, University of York - White Rose Research Online | Institution | 1 |